Watch HIMS. Know when insiders buy.
One email the day a filing lands. Free.
Work order
45
WATCH · insiders 25, shorts 65
Insiders, 90 days
−$1.4M
net selling · 0 buys, 4 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP —P/E —DIV YIELD —FCF YIELD —REV TTM $2.6B +28.0%NET INCOME −$142M −173.4%NET CASH —52W 14.52 – 62.76SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $753.2M | +38.2% | 63.8% | −$97.2M | −$86.3M | −303.0% | -0.37 | −$35.9M | $32.3M | −$68.2M | Aug 10 |
| Q1 2026 · Mar 31 | $608.1M | +3.8% | 65.2% | −$78.3M | −$92.1M | −286.1% | -0.40 | $89.4M | $36.3M | $53.1M | Aug 10 |
| Q4 2025 · Dec 31derived | $617.8M | +28.4% | 71.9% | $9.2M | $20.6M | −20.8% | 0.08 | $61.3M | $63.9M | −$2.6M | Feb 23 |
| Q3 2025 · Sep 30 | $599M | +49.2% | 73.8% | $11.8M | $15.8M | −79.1% | 0.06 | $148.7M | $69.4M | $79.3M | Nov 3 |
| Q2 2025 · Jun 30 | $544.8M | +72.6% | 76.4% | $26.7M | $42.5M | +219.7% | 0.17 | −$19.1M | $50.4M | −$69.5M | Aug 10 |
| Q1 2025 · Mar 31 | $586M | +110.7% | 73.5% | $57.9M | $49.5M | +344.7% | 0.20 | $109.1M | $59M | $50.1M | Aug 10 |
| Q4 2024 · Dec 31derived | $481.1M | +95.1% | 76.8% | $18.6M | $26M | +1990.4% | 0.10 | $86.4M | $26.9M | $59.5M | Feb 23 |
| Q3 2024 · Sep 30 | $401.6M | +77.1% | 79.2% | $22.4M | $75.6M | — | 0.32 | $85.3M | $5.9M | $79.4M | Nov 3 |
| Q2 2024 · Jun 30 | $315.6M | — | 81.3% | $11M | $13.3M | — | 0.06 | $53.6M | $6M | $47.6M | Nov 3 |
| Q1 2024 · Mar 31 | $278.2M | — | 82.4% | $9.9M | $11.1M | — | 0.05 | $25.8M | $14M | $11.8M | Nov 3 |
| Q4 2023 · Dec 31derived | $246.6M | — | 82.7% | −$400K | $1.2M | — | 0.01 | $22M | — | — | Feb 23 |
| Q3 2023 · Sep 30 | $226.7M | — | 82.6% | −$8.6M | −$7.6M | — | -0.04 | $25.2M | — | — | Nov 4 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $2.3B | 73.8% | $105.6M | $128.4M | 5.5% | 0.51 | $300M | $242.6M | $57.4M | $90M | — |
| FY2024 · to Dec 31 | $1.5B | 79.5% | $61.9M | $126M | 8.5% | 0.53 | $251.1M | $52.8M | $198.3M | $83M | — |
| FY2023 · to Dec 31 | $872M | 82.0% | −$29.5M | −$23.5M | -2.7% | -0.11 | $73.5M | $26.5M | $47M | $2M | — |
| FY2022 · to Dec 31 | $526.9M | 77.6% | −$68.7M | −$65.7M | -12.5% | -0.32 | −$26.5M | $7.2M | −$33.7M | $0 | — |
| FY2021 · to Dec 31 | $271.9M | 75.2% | −$115M | −$107.7M | -39.6% | -0.58 | −$34.4M | — | — | $0 | — |
| FY2020 · to Dec 31 | $148.8M | 73.6% | −$15.1M | −$18.1M | -12.2% | -0.51 | −$2.5M | — | — | $0 | — |
Every number comes from Hims & Hers Health, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.